Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001386792 | SCV001587140 | pathogenic | Deficiency of alpha-mannosidase | 2020-07-14 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg805Metfs*13) in the MAN2B1 gene. It is expected to result in an absent or disrupted protein product. For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in MAN2B1 are known to be pathogenic (PMID: 9915946, 22161967). This variant has not been reported in the literature in individuals with MAN2B1-related conditions. This variant is not present in population databases (ExAC no frequency). |
Genome- |
RCV001386792 | SCV002014065 | pathogenic | Deficiency of alpha-mannosidase | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001386792 | SCV005060744 | likely pathogenic | Deficiency of alpha-mannosidase | 2023-12-04 | criteria provided, single submitter | clinical testing |